ARS Pharmaceuticals (SPRY) Stock Price
$11.24 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
7 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on ARS Pharmaceuticals, AI stock picks, stock alerts and much more.
SPRY AI Stock Analysis
AI stock analysis for SPRY is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like ARS Pharmaceuticals (SPRY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
ARS Pharmaceuticals (SPRY) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of ARS Pharmaceuticals (SPRY), currently trading at $11.24, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SPRY
-
ARS Pharmaceuticals, Inc.
-
Symbol
SPRY
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
SPRY Alternative Data
Web Traffic
ARS Pharmaceuticals receives an estimated 18217 monthly visitors to ars-pharma.com.
-
Web Traffic
18217
-
Change from Previous Month
29.7%
-
3 Month Change
8.5%
-
YoY Change
8.5%
News Mentions
ARS Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Reddit Mentions
ARS Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
Twitter Followers
ARS Pharmaceuticals has 496 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.1% over the last month.
-
Twitter Followers
496
-
Daily Change
0.2%
-
1 Month Change
2.1%
-
3 Month Change
6.9%
LinkedIn Followers
8,084 are following ARS Pharmaceuticals on LinkedIn, up by 3.5% over the last month.
-
LinkedIn Followers
8084
-
Daily Change
0%
-
1 Month Change
3.5%
-
3 Month Change
11.2%
Job Postings
ARS Pharmaceuticals currenly has an estimated 5 open job postings, up by 66.7% over the last month.
-
Job Postings
5
-
Daily Change
0%
-
1 Month Change
66.7%
-
3 Month Change
150%
LinkedIn Employees
According to LinkedIn, ARS Pharmaceuticals has 148 employees, up by 0.7% over the last month.
-
LinkedIn Employees
148
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
11.3%
Business Outlook
-
Business Outlook
67
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
SPRY Financials
SPRY Key Metrics
-
Total Revenue
$2.1M
-
Net Income
-$19.1M
-
Earnings per Share
-$0.2
-
Free cash flow
-$14.6M
-
EBITDA
-$21.7M
-
EBITDA Ratio
-10.5164
-
Total Assets
$217.6M
SPRY 2-year Revenue & Income
SPRY 2-year Free Cash Flow
SPRY Technicals
SPRY SMA
SPRY RSI
FAQ
What's the current price of ARS Pharmaceuticals (SPRY) Stock?
The price of an ARS Pharmaceuticals (SPRY) share is $11.24.
What's the market cap of ARS Pharmaceuticals?
The current market cap of ARS Pharmaceuticals is 1.1B.
Should I buy or sell SPRY?
ARS Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, ARS Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is ARS Pharmaceuticals a good investment?
The current analysis of ARS Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in ARS Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy ARS Pharmaceuticals (SPRY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for ARS Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to ARS Pharmaceuticals (SPRY) that investors often compare it to?
ARS Pharmaceuticals (SPRY) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for ARS Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast ARS Pharmaceuticals' stock price to be around $11.49 in 2026. Starting from the current price of $11.24, this represents a 2.2% change in price, indicating a neutral outlook for the stock.
How to buy ARS Pharmaceuticals (SPRY) Stock?
ARS Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy ARS Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.